PharmExec Blog
Follow Us
RSS
Bookstore
Author Archives: Jennifer Ringler
Join the Adherence Conversation
Medication adherence is an ongoing and serious problem; according to the Center for Health Transformation, the annual cost of patients not taking their medicines as prescribed is nearly $300 billion, with approximately 125,000 patients dying each year due to poor adherence—that’s 342 people every day.
Improving adherence rates in the United States has been a [...]
Rare Diseases Lead to Unique Legislation
Since 1983, pharma and patent organizations have been working together to influence policy aimed at improving the lives of those with rare diseases.
In 1983—with the help of Abbey Meyers and the drive she had to help her son (more on that here)—the Orphan Drug Act was passed to incentivize pharma to step up and play [...]
Rare Disease Day: Spotlight on Solidarity
Patients, policymakers and pharmaceutical companies are uniting around rare diseases on the rarest of calendar days, presaging a leap forward in health outcomes and business opportunities.
Aligning humanistic objectives with business incentives is often the sine qua non of effective community activism. This year’s Rare Disease Day – hosted in the US by the National [...]
Posted in Events, FDA, Global, Patient Communication, Strategy, healthcare, leadership, patient education, social media Tagged FDA, NIH, NORD, orphan diseases, patient groups, patient information, Rare Disease Day, rare diseases Leave a comment
A Dialogue on Patient Access Programs
As health reforms sweep in major changes to our nation’s healthcare system, patient assistance and access programs (PAPs) are rapidly evolving to assess and meet new needs. As millions of uninsured Americans gain some form of insurance coverage, manufacturer-sponsored PAPs face unprecedented challenges as they rise up to evolve the PAP model to best address [...]
Going the Distance in Digital Advertising